Thursday, September 24, 2015 9:07:36 AM
Lisa Stepp (PhD/MBA) joined Peregrine 3-2015 as “Sr. Dir./Medical Affairs” - formerly with Gilead, Allos, Genentech, and Wyeth. Here is a summary of her 2 known upcoming presentations (thx BioPh & BamB)...
Sep30-Oct2 2015: “EXL's 17th Medical Science Liaison Best Practices Congress”, SanDiego
“Medical Science Liaisons (MSLs) are a vital part of medical affairs teams and, depending on the size of their company, have many interchangeable functions with other medical affairs professionals. Their main role is to support the dissemination of information to key opinion leaders (KOLs) in a way that not only answers essential medical questions but also strengthens product placement and regulatory compliance.”
http://exlevents.com/17th-medical-science-liaison-best-practices-congress
EXL Events: http://exlevents.com/about-us
Agenda: http://exlevents.com/17th-medical-science-liaison-best-practices-congress/agenda
Oct2 8:45–9am: CHAIRPERSON’S RECAP OF DAY2 - Lisa Stepp, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals
Oct2 9-9:45am: “Strategic MSL Leadership to Improve Operations & Achieve Higher Retention of MSL Teams” - Lisa Stepp, PhD, MBA, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals, Inc.
Oct2 3-3:45pm CLOSING REMARKS - Lisa Stepp, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals, Inc.
Faculty(Lisa Stepp, 1 of 18): http://exlevents.com/17th-medical-science-liaison-best-practices-congress/faculty
Oct7 2015: “Perkin Elmer's Annual Imaging User Group Meeting”, Hopkinton MA
http://go.perkinelmer.com/ImagingUserGroupMeetingTSC2015
Track: “Tissue Imaging – Quantitative Pathology Solutions”
Oct7 9:30-12pm Presentation(1 of 6): Using Technology to Inform Clinical Trial Design, Lisa Stepp, PhD, Sr.Dir./Medical Affairs, Peregrine Pharmaceuticals
= = = = = = = = = = = = = = = = =
Lisa Stepp: http://www.linkedin.com/pub/lisa-stepp-phd-mba/a/942/345
Peregrine Pharmaceuticals (Mar2015-curr 7mos), Sr. Dir./Medical Affairs
Gilead Sciences (Jul2012–curr <=assuming in error), Dir. Clinical Research, Oncology & Inflammation Therapeutics
Allos Therapeutics (Jun2010–Jul2012 2.2yrs), Senior Dir./Medical Affairs
Genentech (Aug2003–Jun2010 6.9yrs), Sr. Reg. Mgr., BioOncology, MSLs
Genentech BioOncology (Feb2003–Aug2003 7mos), Medical Science Liaison
Wyeth (Aug2000–Nov2002 2.3yrs), Medical Science Liaison II
Sep30-Oct2 2015: “EXL's 17th Medical Science Liaison Best Practices Congress”, SanDiego
“Medical Science Liaisons (MSLs) are a vital part of medical affairs teams and, depending on the size of their company, have many interchangeable functions with other medical affairs professionals. Their main role is to support the dissemination of information to key opinion leaders (KOLs) in a way that not only answers essential medical questions but also strengthens product placement and regulatory compliance.”
http://exlevents.com/17th-medical-science-liaison-best-practices-congress
EXL Events: http://exlevents.com/about-us
Agenda: http://exlevents.com/17th-medical-science-liaison-best-practices-congress/agenda
Oct2 8:45–9am: CHAIRPERSON’S RECAP OF DAY2 - Lisa Stepp, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals
Oct2 9-9:45am: “Strategic MSL Leadership to Improve Operations & Achieve Higher Retention of MSL Teams” - Lisa Stepp, PhD, MBA, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals, Inc.
Oct2 3-3:45pm CLOSING REMARKS - Lisa Stepp, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals, Inc.
Faculty(Lisa Stepp, 1 of 18): http://exlevents.com/17th-medical-science-liaison-best-practices-congress/faculty
Oct7 2015: “Perkin Elmer's Annual Imaging User Group Meeting”, Hopkinton MA
http://go.perkinelmer.com/ImagingUserGroupMeetingTSC2015
Track: “Tissue Imaging – Quantitative Pathology Solutions”
Oct7 9:30-12pm Presentation(1 of 6): Using Technology to Inform Clinical Trial Design, Lisa Stepp, PhD, Sr.Dir./Medical Affairs, Peregrine Pharmaceuticals
= = = = = = = = = = = = = = = = =
Lisa Stepp: http://www.linkedin.com/pub/lisa-stepp-phd-mba/a/942/345
Peregrine Pharmaceuticals (Mar2015-curr 7mos), Sr. Dir./Medical Affairs
Gilead Sciences (Jul2012–curr <=assuming in error), Dir. Clinical Research, Oncology & Inflammation Therapeutics
Allos Therapeutics (Jun2010–Jul2012 2.2yrs), Senior Dir./Medical Affairs
Genentech (Aug2003–Jun2010 6.9yrs), Sr. Reg. Mgr., BioOncology, MSLs
Genentech BioOncology (Feb2003–Aug2003 7mos), Medical Science Liaison
Wyeth (Aug2000–Nov2002 2.3yrs), Medical Science Liaison II

